Marc Uknis, Angel Investor

Marc Uknis, MD, FACS, MBA, is a CEO, Philanthropist, and Angel Investor. He is the CEO of CytoGene Therapeutics, using short interfering RNA to improve outcomes in cellular transplantation. She is an Adjunct Associate Professor of Surgery, Microbiology & Applied Physiology at the University of Massachusetts Medical School. Marc is also an angel investor at a Delaware-based angel group focusing on seed investments.